Figure S8 shows that dazostinag with chemotherapy creates an immune-suppressive response in the tumor microenvironment, highlighting CCL2's role.
Figure S8. Dazostinag combinations with chemotherapy elicits an immune-suppressive response in the TME through the upregulation of CCL2.
No takes yet. Share an insight, caveat, or question.
Gregory et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: